| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/02/2000 | EP0975764A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975758A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/02/2000 | EP0975755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975751A1 A tm4sf human tumor-associated antigen |
| 02/02/2000 | EP0975745A1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/02/2000 | EP0975655A1 Improvements in adaptor-based sequence analysis |
| 02/02/2000 | EP0975654A1 Composition and method for treatment of cmv infections |
| 02/02/2000 | EP0975653A1 Recombination of polynucleotide sequences using random or defined primers |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
| 02/02/2000 | EP0975427A1 A device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 02/02/2000 | EP0975363A1 Attenuated respiratory syncytial virus |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0552290B1 Process and apparatus for fragmenting biomaterials |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/02/2000 | CN1243543A Purification and/or concentration of DNA by cross-flow filtration, separation of endotoxins from nucleic acid preparation |
| 02/02/2000 | CN1243163A Diagnosis box for checking glucose-6-phosphodehydrogenase deficiency disease, and preparation method thereof |
| 02/02/2000 | CN1243162A Photosensitive utricule with function of identifying germs and virus, and preparation method thereof |
| 02/01/2000 | US6020481 Fluorescent labeling reagents; dideoxy polynucleotide sequencing and fragment analysis methods. |
| 02/01/2000 | US6020478 Human tumor-associated antigen |
| 02/01/2000 | US6020476 DAZ: a gene family associated with azoospermia |
| 02/01/2000 | US6020473 Nucleic acids encoding variants of vascular endothelial cell growth factor |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020461 Detection of gonorrhea is one area in which nucleic acid hybridization holds great potential as a diagnostic tool in clinical medicine. |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance. |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020187 Flow through nucleic acid hybridisation device |
| 02/01/2000 | US6020186 Device and process for isolating nucleic acids from cell suspensions |
| 02/01/2000 | US6020184 Polyorganosiloxane biodegradation method using a microscopic fungus and screening method |
| 02/01/2000 | US6020181 Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase |
| 02/01/2000 | US6020178 Transglutaminase and gene encoding same |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020163 Lipocalin homolog |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020155 Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression |
| 02/01/2000 | US6020150 Gelled system and method for detecting microorganisms by separation and culture on gelled system |
| 02/01/2000 | US6020149 Combining a microbially required nucleotide phosphatase, a nucleoside phosphate and the substance to be tested, and assessing the extent of degradation of the nucleoside phosphate in the presence and absence of the substance |
| 02/01/2000 | US6020147 Chemical analysis apparatus and method |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020141 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
| 02/01/2000 | US6020138 Methods for detecting nucleic acids by ligation of multiple oligomers |
| 02/01/2000 | US6020137 Methods for the detection of loss of heterozygosity |
| 02/01/2000 | US6020136 Identification of functional transcription factors synthesized in developing neurons |
| 02/01/2000 | US6020135 Monitoring expression of these genes is used to provide indications of p53 status in a cell. such monitoring can also be used to screen for useful anti-cancer therapeutics, as well as for substances which are carcinogenic. |
| 02/01/2000 | US6020134 Method for diagnosing cancer via DNA hybridization |
| 02/01/2000 | US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
| 02/01/2000 | US6020132 Chimeric nucleic acids compounds that have the capacity of forming triplex structures. |
| 02/01/2000 | US6020131 An easy method for detecting a nucleic acid polymer in aqueous phase. |
| 02/01/2000 | US6020130 Nucleic acid ligands that bind to and inhibit DNA polymerases |
| 02/01/2000 | US6020128 DNA polymerase from Treponema pallidum |
| 02/01/2000 | US6020127 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 02/01/2000 | US6020126 Rapid genetic screening method |
| 02/01/2000 | US6020124 Detection of soluble gene sequences in biological fluids |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6020121 Screening for an inhibitor of a global regulator of pathogenesis genes |
| 02/01/2000 | US6020052 Laminated membrane structure for polarographic measurement and methods of making said structures |
| 02/01/2000 | US6019896 Method for using a quality metric to assess the quality of biochemical separations |
| 02/01/2000 | US6019734 Patch impregnated with potassium hydroxide applied to carrier; ph detector |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2105492C Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/27/2000 | WO2000004390A2 Microdevices for screening biomolecules |
| 01/27/2000 | WO2000004384A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | WO2000004378A1 Method for assaying l-phenylalanine and l-phenylalanine sensor |
| 01/27/2000 | WO2000004196A2 Cis acting nucleic acid elements and methods of use |
| 01/27/2000 | WO2000004195A1 Archiving of vectors |
| 01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | WO2000004193A1 Method for detecting nucleic acids using target-mediated ligation of bipartite primers |
| 01/27/2000 | WO2000004192A1 Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
| 01/27/2000 | WO2000004191A1 Methods and devices for detection of xenogeneic graft persistence and infectious agents |
| 01/27/2000 | WO2000004190A1 Evolution of whole cells and organisms by recursive sequence recombination |
| 01/27/2000 | WO2000004188A2 Methods and compositions for comparing and normalizing assays |
| 01/27/2000 | WO2000004187A2 Methods and kits for diagnosing and determination of the predisposition of diseases |
| 01/27/2000 | WO2000004186A1 Method for identifying mutants and molecules |
| 01/27/2000 | WO2000004185A1 Adenoviral based promoter assay |
| 01/27/2000 | WO2000004184A1 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
| 01/27/2000 | WO2000004178A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | WO2000004174A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | WO2000004169A1 New caspase homologue |
| 01/27/2000 | WO2000004160A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004159A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004156A2 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 01/27/2000 | WO2000004152A2 Androgen receptor coactivators |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004140A1 71 human secreted proteins |
| 01/27/2000 | WO2000004137A1 Human aspartic proteases |